Published in J Virol on April 23, 2008
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet (2000) 336.52
Toll-like receptors and innate immunity. Nat Rev Immunol (2001) 16.50
Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments. FEBS Lett (2004) 11.00
Cancer and the chemokine network. Nat Rev Cancer (2004) 10.27
RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides. Cell (1999) 8.55
Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev (2006) 7.92
Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol (2000) 7.78
Matrix metalloproteinases: biologic activity and clinical implications. J Clin Oncol (2000) 4.98
Roles of HMGA proteins in cancer. Nat Rev Cancer (2007) 3.98
Role of Src expression and activation in human cancer. Oncogene (2000) 3.41
Bacterial lipopolysaccharide activates NF-kappaB through toll-like receptor 4 (TLR-4) in cultured human dermal endothelial cells. Differential expression of TLR-4 and TLR-2 in endothelial cells. J Biol Chem (2000) 3.06
Interleukin-12: biological properties and clinical application. Clin Cancer Res (2007) 3.00
Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias. Clin Cancer Res (2000) 2.86
Murine retroviruses activate B cells via interaction with toll-like receptor 4. Proc Natl Acad Sci U S A (2002) 2.70
KIT (CD117): a review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation. Appl Immunohistochem Mol Morphol (2005) 2.43
Complement: a unique innate immune sensor for danger signals. Mol Immunol (2004) 2.42
Equine connective tissue tumors contain unintegrated bovine papilloma virus DNA. J Virol (1980) 1.90
The multifaceted roles of chemokines in malignancy. Cancer Metastasis Rev (2006) 1.90
Chemokines and cancer: migration, intracellular signalling and intercellular communication in the microenvironment. Biochem J (2008) 1.83
Activated leukocyte cell adhesion molecule: a new paradox in cancer. Transl Res (2007) 1.49
The nature of the MHC class I peptide loading complex. Immunol Rev (1999) 1.48
Bovine papillomavirus infection in equine sarcoids and in bovine bladder cancers. Vet J (2006) 1.45
Rho GDP dissociation inhibitor protects cancer cells against drug-induced apoptosis. Cancer Res (2005) 1.40
Fra-1 a target for cancer prevention or intervention. Gene (2006) 1.35
Retracted High-mobility group A1 inhibits p53 by cytoplasmic relocalization of its proapoptotic activator HIPK2. J Clin Invest (2007) 1.34
In vivo regulation of cell death by embryonic (pro)insulin and the insulin receptor during early retinal neurogenesis. Development (2000) 1.29
Characterization of GMP-17, a granule membrane protein that moves to the plasma membrane of natural killer cells following target cell recognition. Proc Natl Acad Sci U S A (1996) 1.25
Neuropeptides and their receptors: innovative science providing novel therapeutic targets. Br J Pharmacol (2006) 1.24
Down-regulation of CXCL5 inhibits squamous carcinogenesis. Cancer Res (2006) 1.23
Cell proliferation and survival induced by Toll-like receptors is antagonized by type I IFNs. Proc Natl Acad Sci U S A (2007) 1.19
E5 protein of human papillomavirus 16 downregulates HLA class I and interacts with the heavy chain via its first hydrophobic domain. Int J Cancer (2006) 1.18
Gene profiling in Pap-cell smears of high-risk human papillomavirus-positive squamous cervical carcinoma. Gynecol Oncol (2007) 1.14
Inhibitor of apoptosis protein-1 promotes tumor cell survival in mesothelioma. Carcinogenesis (2002) 1.14
CXCL5 overexpression is associated with late stage gastric cancer. J Cancer Res Clin Oncol (2007) 1.08
Down-regulation of MHC class I by bovine papillomavirus E5 oncoproteins. Oncogene (2002) 1.03
The E7 protein of cutaneous human papillomavirus type 8 causes invasion of human keratinocytes into the dermis in organotypic cultures of skin. Cancer Res (2005) 1.01
Fra-1 targets the AP-1 site/2G single nucleotide polymorphism (ETS site) in the MMP-1 promoter. Eur J Biochem (2003) 0.97
The bovine papillomavirus oncoprotein E5 retains MHC class I molecules in the Golgi apparatus and prevents their transport to the cell surface. Oncogene (2002) 0.96
Uridine phosophorylase: an important enzyme in pyrimidine metabolism and fluoropyrimidine activation. Drugs Today (Barc) (2004) 0.96
Generating MHC class I ligands from viral gene products. Immunol Rev (1999) 0.94
c-Src activation by the E5 oncoprotein enables transformation independently of PDGF receptor activation. Oncogene (2002) 0.90
Establishment and characterization of equine fibroblast cell lines transformed in vivo and in vitro by BPV-1: model systems for equine sarcoids. Virology (2008) 0.89
Mitotic kinesin-like protein 2 binds and colocalizes with papillomavirus E2 during mitosis. J Virol (2006) 0.89
Bovine papillomavirus load and mRNA expression, cell proliferation and p53 expression in four clinical types of equine sarcoid. J Gen Virol (2007) 0.88
Clinical survey of tumours and tumour-like lesions in horses in south east Queensland. Equine Vet J (1981) 0.85
Sequence variants of bovine papillomavirus E5 detected in equine sarcoids. Virus Res (2003) 0.85
Up-regulated expression of the uridine phosphorylase gene in human gastric tumors is correlated with a favorable prognosis. Anticancer Res (2007) 0.85
Characterization of BPV-like DNA in equine sarcoids. Arch Virol (1991) 0.84
Expression of cell cycle associated proteins cyclin A, CDK-2, p27kip1 and p53 in equine sarcoids. Cancer Lett (2005) 0.83
Detection of bovine papillomavirus type 1 genomes and viral gene expression in equine inflammatory skin conditions. Virus Res (2006) 0.81
The diagnosis and treatment of periorbital sarcoid in the horse: 445 cases from 1974 to 1999. Vet Ophthalmol (2000) 0.81
Human papillomavirus type 16 E6 protein up-regulates the expression of the high mobility group protein HMG-I(Y) gene in mouse 10T1/2 cells. Virus Res (1996) 0.80
Generation and performance of an equine-specific large-scale gene expression microarray. Am J Vet Res (2004) 0.80
Equine sarcoids. Vet Clin North Am Equine Pract (1998) 0.80
Similarities and differences between the E5 oncoproteins of bovine papillomaviruses type 1 and type 4: cytoskeleton, motility and invasiveness in E5-transformed bovine and mouse cells. Virus Res (2005) 0.79
Receptor modulation in viral replication: HIV, HSV, HHV-8 and HPV: same goal, different techniques to interfere with MHC-I antigen presentation. Curr Top Microbiol Immunol (2005) 0.79
Sarcoids in captive zebras (Equus burchellii): association with bovine papillomavirus type 1 infection. J Zoo Wildl Med (2005) 0.79
Downregulation of major histocompatibility complex class I in bovine papillomas. J Gen Virol (2004) 0.78
Identification and functional analysis of sequence variants in the long control region and the E2 open reading frame of bovine papillomavirus type 1 isolated from equine sarcoids. Virology (2007) 0.78
Evaluation of excision, cryosurgery and local BCG vaccination for the treatment of equine sarcoids. Vet Rec (2001) 0.78
Connective tissue composition of the equine sarcoid. Equine Vet J (1982) 0.78
Enzymatic activities of uridine and thymidine phosphorylase in normal and cancerous uterine cervical tissues. Hum Cell (2007) 0.77
The E5 protein of BPV-4 interacts with the heavy chain of MHC class I and irreversibly retains the MHC complex in the Golgi apparatus. Oncogene (2006) 0.76
Conservation of cytoplasmic poly (A)-containing RNA in mouse and rat. Nature (1975) 2.18
Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization. Virology (1996) 2.08
Evolution of human papillomavirus type 18: an ancient phylogenetic root in Africa and intratype diversity reflect coevolution with human ethnic groups. J Virol (1993) 1.99
Studies on vaccination against papillomaviruses: prophylactic and therapeutic vaccination with recombinant structural proteins. Virology (1991) 1.70
Transcriptional control signals in the genome of bovine papillomavirus type 1. Nature (1983) 1.70
Vaccination of cattle with the N-terminus of L2 is necessary and sufficient for preventing infection by bovine papillomavirus-4. Virology (1995) 1.48
Persistence and transmission of natural type I feline coronavirus infection. J Gen Virol (2003) 1.36
Persistence of non-integrated viral DNA in bovine cells transformed in vitro by bovine papillomavirus type 2. Nature (1981) 1.35
Vaccination of cattle with bovine papillomavirus type 4 L2 elicits the production of virus-neutralizing antibodies. J Gen Virol (1996) 1.32
Variation of human papillomavirus type 6 (HPV-6) and HPV-11 genomes sampled throughout the world. J Clin Microbiol (1995) 1.25
Tandem integration of complete and defective SV40 genomes in mouse-human somatic cell hybrids. Cell (1978) 1.24
Reactive astrocytes and Wnt/β-catenin signaling link nigrostriatal injury to repair in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease. Neurobiol Dis (2010) 1.17
Two classes of messenger RNA in cultured rat cells: repetitive sequence transcripts and unique sequence transcripts. J Mol Biol (1974) 1.16
Inflammatory biomarkers in blood of patients with acute brain ischemia. Eur J Neurol (2006) 1.16
Studies on vaccination against papillomaviruses: a comparison of purified virus, tumour extract and transformed cells in prophylactic vaccination. Vet Rec (1990) 1.15
Unintegrated viral DNA sequences in a hamster tumor induced by bovine papilloma virus. J Virol (1981) 1.14
Molecular heterogeneity and lesion site specificity of cutaneous bovine papillomaviruses. Virology (1981) 1.13
Studies on vaccination against papillomaviruses: the immunity after infection and vaccination with bovine papillomaviruses of different types. Vet Rec (1990) 1.11
Effectiveness of a manual disinfection procedure in eliminating hepatitis C virus from experimentally contaminated endoscopes. Gastrointest Endosc (1999) 1.09
alpha6 integrin is not the obligatory cell receptor for bovine papillomavirus type 4. J Gen Virol (2000) 1.09
Association of bovine papillomavirus with the equine sarcoid. J Gen Virol (2003) 1.07
The B subgroup bovine papillomaviruses lack an identifiable E6 open reading frame. Mol Carcinog (1991) 1.06
Diagnosis of equid herpesviruses -1 and -4 by polymerase chain reaction. Equine Vet J (1992) 1.02
Multiple interactions between cellular factors and the non-coding region of human papillomavirus type 16. J Gen Virol (1990) 1.01
Production of biologically active equine interleukin 12 through expression of p35, p40 and single chain IL-12 in mammalian and baculovirus expression systems. Equine Vet J (2001) 1.00
DNA-RNA hybridization. Philos Trans R Soc Lond B Biol Sci (1975) 0.99
The nucleotide sequence and genome organization of bovine papillomavirus type 4. J Gen Virol (1987) 0.99
A longitudinal study of feline immunodeficiency virus-specific cytotoxic T lymphocytes in experimentally infected cats, using antigen-specific induction. J Virol (1996) 0.99
Molecular cloning and characterization of human papillomavirus type 7 DNA. Virology (1986) 0.98
A novel bovine papillomavirus (BPV-6) causing true epithelial papillomas of the mammary gland skin: a member of a proposed new BPV subgroup. Virology (1984) 0.98
Down-regulation of MHC class I is a property common to papillomavirus E5 proteins. Virus Res (2006) 0.98
Bovine papillomavirus E5 oncoprotein binds to the activated form of the platelet-derived growth factor beta receptor in naturally occurring bovine urinary bladder tumours. Oncogene (2006) 0.96
The bovine papillomavirus type 4 E8 protein binds to ductin and causes loss of gap junctional intercellular communication in primary fibroblasts. J Virol (1996) 0.95
Guidelines of the French Society of Digestive Endoscopy: recommendations for setting up cleaning and disinfection procedures in gastrointestinal endoscopy. Endoscopy (2000) 0.95
Estrogen, neuroinflammation and neuroprotection in Parkinson's disease: glia dictates resistance versus vulnerability to neurodegeneration. Neuroscience (2005) 0.94
Feline leukemia virus DNA vaccine efficacy is enhanced by coadministration with interleukin-12 (IL-12) and IL-18 expression vectors. J Virol (2001) 0.93
Repetitious and unique sequences in the heterogeneous nuclear and cytoplasmic messenger RNA of mammalian and insect cells. Cell (1974) 0.92
Both viral E2 protein and the cellular factor PEBP2 regulate transcription via E2 consensus sites within the bovine papillomavirus type 4 long control region. J Virol (1995) 0.92
Metabolic syndrome in patients with hypertension attending a family practice clinic in Jordan. East Mediterr Health J (2010) 0.92
Role of different sponge cell types in species specific cell aggregation. Nat New Biol (1971) 0.91
Endoscope drying/storage cabinet: interest and efficacy. J Hosp Infect (2007) 0.91
Cloning and sequencing of equine transforming growth factor-beta 1 (TGF beta-1) cDNA. DNA Seq (1997) 0.90
Detection of canine herpesvirus 1 in a wide range of tissues using the polymerase chain reaction. Vet Microbiol (1996) 0.90
Establishment and characterization of equine fibroblast cell lines transformed in vivo and in vitro by BPV-1: model systems for equine sarcoids. Virology (2008) 0.89
Complete DNA sequence of canine adenovirus type 1. J Gen Virol (1997) 0.88
Equine telomeres and telomerase in cellular immortalisation and ageing. Mech Ageing Dev (2003) 0.88
The effect of dexamethasone on growth and differentiation of bone-marrow derived mucosal mast cells in vitro. Immunology (1987) 0.88
DNA sequences of human papillomavirus types 11, 16, and 18 in lesions of the uterine cervix in the west of Scotland. Br Med J (Clin Res Ed) (1986) 0.87
The enhancer in the long control region of human papillomavirus type 16 is up-regulated by PEF-1 and down-regulated by Oct-1. J Virol (1995) 0.87
Molecularly cloned bovine papillomavirus DNA transforms mouse fibroblasts in vitro. J Gen Virol (1983) 0.86
Suppression of IgE responses by hyperimmune serum in rats. Immunology (1986) 0.86
Human papillomavirus DNA in biopsies of oral tissues. J Gen Virol (1991) 0.86
The biology of papillomaviruses and their role in oncogenesis. Anticancer Res (1985) 0.86
Biosynthesis and distribution of ribosomal particles in the cellular slime mould, Dictyostelium purpureum. J Mol Biol (1970) 0.85
E5 transforming proteins of papillomaviruses do not disturb the activity of the vacuolar H(+)-ATPase. J Gen Virol (2001) 0.85
[Validation of a sampling method for the channels of a flexible endoscope which is experimentally contaminated]. Pathol Biol (Paris) (1998) 0.85
Lactobacillus jensenii prosthetic valve endocarditis. J Infect (1990) 0.85
Telomerase: a potential diagnostic and therapeutic tool in canine oncology. Vet Pathol (2003) 0.85
Positive and negative E2-independent regulatory elements in the long control region of bovine papillomavirus type 4. J Gen Virol (1991) 0.85
Sequence variants of bovine papillomavirus E5 detected in equine sarcoids. Virus Res (2003) 0.85
Phenotypical characterization of lymphocytes infiltrating regressing papillomas. J Virol (1996) 0.85
Characterization of a nuclear factor, papilloma enhancer binding factor-1, that binds the long control region of human papillomavirus type 16 and contributes to enhancer activity. Mol Carcinog (1993) 0.84
Molecular cloning of bovine papillomavirus genomes and comparison of their sequence homologies by heteroduplex mapping. J Gen Virol (1982) 0.84
Presence of beta human papillomaviruses in nonmelanoma skin cancer from organ transplant recipients and immunocompetent patients in the West of Scotland. Br J Dermatol (2009) 0.84
Guidelines of the French Society of Digestive Endoscopy: biliary stenting. Endoscopy (2002) 0.84
Neuroendocrine-immune (NEI) circuitry from neuron-glial interactions to function: Focus on gender and HPA-HPG interactions on early programming of the NEI system. Immunol Cell Biol (2001) 0.84
Risk factors for the carriage of Campylobacter upsaliensis by dogs in a community in Cheshire. Vet Rec (2009) 0.83
Analysis of the transforming functions of bovine papillomavirus type 4. Virology (1993) 0.83
Telomerase reverse transcriptase (TERT) expression and proliferation in canine brain tumours. Neuropathol Appl Neurobiol (2006) 0.83
Oncolytic gene therapy for canine cancers: teaching old dog viruses new tricks. Vet Comp Oncol (2009) 0.83
Opioid-immune interactions in autism: behavioural and immunological assessment during a double-blind treatment with naltrexone. Ann Ist Super Sanita (1996) 0.83
A novel silencer element in the bovine papillomavirus type 4 promoter represses the transcriptional response to papillomavirus E2 protein. J Virol (2001) 0.83
Cooperation between bovine papillomavirus type 4 and ras in the morphological transformation of primary bovine fibroblasts. J Gen Virol (1990) 0.82
Luteinizing hormone-releasing hormone signaling at the lymphocyte involves stimulation of interleukin-2 receptor expression. Endocrinology (1991) 0.82
Extensive papillomatosis of the bovine upper gastrointestinal tract. J Comp Pathol (2003) 0.82
Human papillomavirus 16 L2 inhibits the transcriptional activation function, but not the DNA replication function, of HPV-16 E2. Virus Res (2005) 0.82
Immunoglobulin genes expressed by B-lymphocytes infiltrating cervical carcinomas show evidence of antigen-driven selection. Cancer Immunol Immunother (2001) 0.82
Vaccination of sarcoid-bearing donkeys with chimeric virus-like particles of bovine papillomavirus type 1. J Gen Virol (2008) 0.82
Linear B-cell epitopes in the N-terminus of L2 of bovine papillomavirus type 4. Res Vet Sci (1997) 0.81
Disease- and cell-type-specific transcriptional targeting of vectors for osteoarthritis gene therapy: further development of a clinical canine model. Rheumatology (Oxford) (2005) 0.81
Stress, glucocorticoids and the susceptibility to develop autoimmune disorders of the central nervous system. Neurol Sci (2001) 0.81
Studies on glycoprotein 13 (gp13) of equid herpesvirus 1 using affinity-purified gp13, glycoprotein-specific monoclonal antibodies and synthetic peptides in a hamster model. J Gen Virol (1991) 0.81
Ribosomal subunits in Dictyostelium discoideum. The effect of an ionic detergent and a nonionic detergent. Biochim Biophys Acta (1969) 0.81
Basic fibroblast growth factor (bFGF) acts on both neurons and glia to mediate the neurotrophic effects of astrocytes on LHRH neurons in culture. Synapse (2000) 0.81
An enhanced epithelial response of a papillomavirus promoter to transcriptional activators. J Biol Chem (1999) 0.81
Bovine papillomavirus type 1 DNA and E5 oncoprotein expression in water buffalo fibropapillomas. Vet Pathol (2009) 0.81
Bovine papillomavirus type 4 in oesophageal papillomas of cattle from the south of Italy. J Comp Pathol (2003) 0.81
The reproductive system at the neuroendocrine-immune interface: focus on LHRH, estrogens and growth factors in LHRH neuron-glial interactions. Domest Anim Endocrinol (2003) 0.80
Endoscopic management of patients with familial adenomatous polyposis (FAP) following a colectomy. Endoscopy (2005) 0.80